Indication
Nontuberculous Mycobacteria Infection
5 clinical trials
7 products
Product
DelpazolidClinical trial
A Phase 2a, Open-label, Single-arm, Multi-center Study to Evaluate the Efficacy and Safety of LCB01-0371 (Delpazolid) as Add-on Therapy in Patients With Refractory Mycobacterium Abscessus Complex Pulmonary DiseaseStatus: Active (not recruiting), Estimated PCD: 2025-07-29
Clinical trial
A Phase 1b, Multi-center Study of Intravenous (IV) Gallium Nitrate in Patients With Cystic Fibrosis (CF) Who Are Colonized With Nontuberculous Mycobacteria (NTM) (The ABATE Study)Status: Recruiting, Estimated PCD: 2024-09-30
Product
Gallium nitrateClinical trial
Hypertonic Saline for Treatment of Pulmonary Mycobacterium Avium Complex (MAC) DiseaseStatus: Recruiting, Estimated PCD: 2025-06-30
Product
Hypertonic salineClinical trial
A Prospective Standardized Assessment of People With Cystic Fibrosis and Non-tuberculosis Mycobacteria Pulmonary Disease Undergoing Treatment With Mycobacteriophage (POSTSTAMP)Status: , Estimated PCD: 2026-12-01
Product
mycobacteriophageClinical trial
Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex DiseaseStatus: Recruiting, Estimated PCD: 2025-02-28
Product
AzithromycinProduct
EthambutolProduct
Rifampin